Iron can reduce doxorubicin-induced cardiotoxicity S2
The supplemental file includes: Table S1 . Renal function according to iron diet, DOX treatment and supplementation with FCM Table S2 . Renal oxidative stress according to iron diet, DOX treatment and supplementation with FCM Table S3 . Renal histological and immunohistochemical assessment according to iron diet, DOX treatment and supplementation with FCM Figure S1 . Immunohistochemical evaluation of nitrosative stress in the kidney Figure S2 .
Materials and Methods

Immunohistochemical evaluation of inflammation in the kidney
Iron can reduce doxorubicin-induced cardiotoxicity
S3
Supplementary Methods
Modulation of DOX-induced kidney toxicity with FCM After 3 weeks acclimatisation, 6 week old male SHR-SP (n=64) were randomised into eight groups (Groups 1-8; n=8/group). Groups 1-6 were fed LID while Groups 7 and 8 were fed ND for 7 weeks. Then, Groups 1-5 and Group 8 received 6 weekly 0.5 mL i.p injections of DOX at 4 mg/kg BW. In addition, starting at the second weekly DOX injection, Groups 1 and 2 received 5 weekly 0.5 mL intravenous (i.v.) injections of ferric carboxymaltose (FCM) at 3 mg iron/kg BW in 0.5 ml concurrent with or 3 days after DOX treatment, respectively, while Iron can reduce doxorubicin-induced cardiotoxicity S7 Data presented as mean+SD. MDA, malondialdehyde; CuZn-SOD, copper-zinc superoxide dismutase; GPx, glutathione peroxidase; GSH:GSSG, reduced:oxidized glutathione.
* p<0.01 vs. G3 to G8 † p<0.01 vs. G5 to G8 ‡ p<0.01 vs. G5, G7 and G8 § p<0.01 vs. G6 to G8 ǁ p<0.01 vs. G7 to G8 ¶ p<0.01 vs. G8
Iron can reduce doxorubicin-induced cardiotoxicity S8 in kidney sections from ND-fed rats treated with DOX and FCM (G8), followed by LID-fed rats treated with DOX (G5) and LID-fed rats treated with saline (G6). In LID-fed rats treated with DOX and FCM (G1-G4), staining was lower compared to G5, whereas only low levels of staining were seen in LID-fed rats treated with saline (G7). Similar Group trends were observed with iNOS immunostaining. Original magnification, x400.
Iron can reduce doxorubicin-induced cardiotoxicity S10 Figure S2 . Immunohistochemical evaluation of inflammation in the kidney.
Representative light micrographs of kidney sections from Groups 1-8 (G1-G8)
immunostained with antibodies against TNF-α (panel A) or IL-6 (panel B) and counterstained with hematoxylin. Significant proinflammatory cytokine immunostaining is seen in kidney sections from ND-fed rats treated with DOX and FCM (G8) and in LID-fed rats treated with DOX (G5). Lowest degree of staining is seen in ND-fed rats treated with saline (G7). In LIDfed rats treated with DOX and FCM (G1-G4), a moderate level of staining is observed similar to that seen in LID-fed rats treated with DOX only (G6). Original magnification, x400.
